Adenovirus-vectored SARS-CoV-2 vaccine expressing S1-N fusion protein is a research paper published in Antibody Therapeutics (2022). On theSindex it has a DataRank of 0. It has been cited 15 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: UM1-AI106701
National Institutes of Health
Grant: R21-AI130180
National Institutes of Health
Grant: U01-CA233085
National Institutes of Health
Grant: DK130897
UPMC Enterprises
Grant: IPA 25565
NCI NIH HHS
Grant: U01 CA233085
NIAID NIH HHS
Grant: R21 AI130180
NIDDK NIH HHS
Grant: R01 DK130897
NCI NIH HHS
Grant: R21 CA259636
NIAID NIH HHS
Grant: UM1 AI106701
National Institutes of Health
Grant: 3UM1AI106701-12S1
AIDS Clinical Trial Group Laboratory Center
National Institutes of Health
Grant: 5R21AI130180-02
Pre-clinical evaluation of a Zika virus vaccine
National Institutes of Health
Grant: 5R01DK130897-02
Systemic immunoregulatory consequences of bacterial translocation during health and disease
National Institutes of Health
Grant: 7U01CA233085-02
U01 Proposal Transfer - 2021
FWCI
1.45
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals